<SEC-DOCUMENT>0001354457-26-000219-index.html : 20260226
<SEC-HEADER>0001354457-26-000219.hdr.sgml : 20260226
<ACCEPTANCE-DATETIME>20260226104939
ACCESSION NUMBER:		0001354457-26-000219
CONFORMED SUBMISSION TYPE:	CERT
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20260226
DATE AS OF CHANGE:		20260226
EFFECTIVENESS DATE:		20260226

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Atrium Therapeutics, Inc.
		CENTRAL INDEX KEY:			0002093101
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CERT
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-43008
		FILM NUMBER:		26682764

	BUSINESS ADDRESS:	
		STREET 1:		3020 CALLAN ROAD
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		858-401-7900

	MAIL ADDRESS:	
		STREET 1:		3020 CALLAN ROAD
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Bryce Therapeutics, Inc.
		DATE OF NAME CHANGE:	20251022
</SEC-HEADER>
<DOCUMENT>
<TYPE>CERT
<SEQUENCE>1
<FILENAME>RNA_Form10_Cert_2093101.pdf
<TEXT>
Document 1 - file: RNA_Form10_Cert_2093101.pdf

</DOCUMENT>
</SEC-DOCUMENT>